Novartis Cuts 2,000 Jobs In Switzerland And U.S., Pricing Pressures To Blame
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis intends to improve productivity and absorb pricing pressures by closing two Swiss manufacturing facilities and transferring some research to the U.S.